Filed with 60.21 Psychology · Related: 60.12 Self-Improvement · Ethics & Metaethics (MOC)

Anxiety[Borderline Personality Disorder]]te created: Monday, May 13th 2024, 5:20:30 pm
date modified: Monday, May 13th 2024, 5:24:53 pm
related:
Genre:
URL:
tags:
Category: Course
Author:

• Dr. Robert O. Pihl at Peterson Academy

---

Defining Mental Illness

This lecture serves as a critical introduction to the field of Abnormal Psychology, focusing less on a catalog of facts and more on developing a “way of thinking” about mental illness. The professor argues that the field is currently defined more by social consensus and bureaucratic labeling than by clear biological causation.

---

1. The Challenge of Definition

The terms “abnormal psychology,” “psychopathology,” and “mental illness” are used interchangeably, yet they are notoriously difficult to define.

• Statistical Limits: While “abnormal” implies a departure from the norm (standard deviations), this fails in practice. For instance, a high IQ and a low IQ are statistically equidistant from the norm, but they are not treated as equally “abnormal.”
• Majority Vote: The lecturer posits that mental illnesses are often defined by a “majority vote” of committees rather than objective discovery.
• Perspective over Facts: Citing Alfred North Whitehead, the lecturer emphasizes that how we think is more important than what we know, especially since “knowledge is more perishable than fresh fish.”

---

2. The “Inflation” of Mental Disorders

A central theme is the dramatic growth of the Diagnostic and Statistical Manual (DSM), the “bible” of psychiatry:

This “disorder inflation” suggests that we are labeling more behaviors as illnesses rather than witnessing a biological epidemic. The lecturer notes that etiology (causation) remains largely unknown, and pharmacological treatments have been “spectacularly unsuccessful.”

---

3. Case Studies: Autism and ADHD

The professor uses these two disorders to illustrate how social and bureaucratic factors influence prevalence rates.

Autism Spectrum Disorder (ASD)

• The Growth: Since being added to the DSM-III in 1980, rates have exploded.
• Diagnostic Substitution: Some of the increase is due to children previously labeled with “mental retardation” now being classified as autistic.
• Male Brain Hypothesis: There is a 4:1 male-to-female ratio. Research suggests a correlation between fetal testosterone levels and later autistic traits.

ADHD and “Bureaucratic” Diagnosis

• The “Redshirt” Effect: A study showed that children born just before school age-cutoffs (the youngest in their class) are significantly more likely to be diagnosed with ADHD and medicated.
• Conclusion: This suggests many diagnoses are actually labels for developmental immaturity rather than brain dysfunction.

---

4. Violence and Mental Illness

The lecture corrects common public misconceptions regarding the link between mental illness and violence:

• The Reality: Only about 25% of mass murderers meet the criteria for mental illness; social and environmental factors are often more predictive.
• The Victim Fallacy: People with severe mental illness are 11 times more likely to be victims of violent crime than the general population.

---

5. Global Burden and Cost

Despite the ambiguity of definitions, the human and economic toll is staggering:

• Prevalence: 1 in 8 people globally (970 million) live with a mental disorder.
• Demographics: Young people are the most at-risk group.
• Economic Impact: Mental illness is the #1 cause of lost economic output and disability, yet it receives significantly less funding than cancer or cardiovascular disease.

---

The Professor’s Summary: “Definitions are merely about the use of words… it makes no sense to ask whether they are true or false.” The goal of the course is to understand the nature of the information used to apply these labels and the consequences of doing so.

Shifts in Mental Health Care

This second lecture shifts focus from the growth of the DSM to the practical and scientific realities of how mental illness is measured, treated, and understood through history. The professor argues that while we have moved away from chains and cages, our modern “medical model” remains fraught with diagnostic circularity and a reliance on drugs that may be less effective than we believe.

---

1. The Legacy of Deinstitutionalization

The movement to close large mental institutions in the 1960s was driven by the hope that antipsychotic drugs would allow patients to live in the community

• The Reality: The number of institutionalized patients dropped from 600,000 to under 100,000, but many migrated to the streets or jails.
• The “New” Institutions: Today, the largest mental health providers in the US are the LA County Jail and the Cook County Jail.
• Frequent Flyers: Mentally ill individuals are arrested at double the rate of the general population for the same infractions.

---

2. Comorbidity and the “P Factor”

In clinical practice, having only one disorder is the exception; comorbidity (having two or more) is the rule.

• Factor Analysis: Studies show that disorders cluster into “Externalizing” (substance abuse, antisocial behavior) and “Internalizing” (anxiety, depression)
• The General Factor (3$P$): Much like general intelligence (4$g$), researchers propose a 5$P$ factor—a general underlying susceptibility to psychopathology
• Symptom Overlap: Many “disorders” share the same symptoms (e.g., aggression), leading to the question: Are these truly separate diseases or just different expressions of the same problem?7

---

3. The Pharmacology Crisis

The professor presents a sobering view of modern psychiatric treatment:

• The 15% Rule: Recent meta-analyses (including unpublished data) suggest the true efficacy of antidepressants is around 15%, while the placebo effect accounts for 20–40% of improvement.
• The “Me Too” Drug Trap: Developing a truly new psychiatric drug takes ~18 years and $2.6 billion, with only a 7% success rate. Consequently, most “new” drugs are just slight molecular tweaks of existing ones to renew patents.
• Treatment Gap: Roughly two-thirds of people with diagnosable disorders never receive treatment, yet many people with no disorder are prescribed psychotropic medication by GPs.

---

4. The “Stickiness” of Labels: The Rosenhan Study

The 1973 study “On Being Sane in Insane Places” remains a cornerstone of the professor’s critique:

The Experiment: Eight sane people gained admission to mental hospitals by faking a single symptom (“hearing voices saying ‘thud’”) Once admitted, they acted perfectly normal.

The Result: Not one was detected as “sane” by staff. They were discharged with “Schizophrenia in Remission.”

• Hypothesis Myopia: Once a label is applied, all behavior is interpreted through that lens. (e.g., a patient taking notes was described by nurses as “engaging in writing behavior”).

---

5. Historical Models of Abnormality

The lecture traces how we have explained “madness” over time:

---

6. The Scientific Goal: Description to Control

The professor highlights the difference between anecdote and empiricism:

• Circular Reasoning: “Why does he hear voices? Because he’s schizophrenic. How do we know he’s schizophrenic? Because he hears voices.” Science must break this circle.
• Description is the Base: We must describe behavior accurately before we can measure, predict, or control it.
• The Power of Culture: Interestingly, schizophrenia recovery rates are often higher in “developing” or collective cultures than in the West, suggesting that social roles and community support are more therapeutic than our high-standard, individualistic society.

---

Philosophy Focus: Aristotle vs. Plato

The professor notes that even the “greats” were often right or wrong for the wrong reasons:

• Aristotle: Believed the heart was the center of the mind because it reacts to emotion (Correct observation, wrong conclusion).
• Plato: Believed the brain was the center because it is closest to God (Correct conclusion, mystical/incorrect reasoning).
• The Lesson: This is why we perform experiments—to move past “common sense” and authority into verifiable facts.

---

Classifying Mental Disorders

This lecture explores the transition from simple historical views of mental illness to modern, sophisticated frameworks like the Complex Medical Model and the Labeling Model. It also critiques the current state of psychiatric diagnosis (the DSM) and looks toward future research-based systems.

---

1. The Labeling Model: Context and Consequence

This model argues that “abnormal” behavior is often defined more by where it occurs than what the behavior is.

• Cultural Relativity: Behaviors like pedophilia are abhorrent in the West but practiced in others; similarly, Western norms regarding dress or beliefs may be seen as abnormal elsewhere.
• The Power of Words: Labeling changes how individuals view themselves and how they are treated.
  • Example: Calling someone “blind” vs. “visually impaired” changes their level of functional independence.
• Permanency: As seen in the Rosenhan study, a psychiatric label is often “indelibly inked.” Once labeled, individuals often assume “sick roles” that facilitate the permanency of the disorder.

---

2. The Complex Medical Model

The professor distinguishes between a “simple” illness model and a more nuanced “complex” version used in modern medicine.

Case Study: Alcoholism

• The Simple Model: AA’s “one drink, one drunk” suggests a genetic vulnerability leading to total loss of control.
• The Modern View: Research (e.g., the vodka/tonic study) shows that an alcoholic’s behavior is often controlled by cognition (what they believe they are drinking) rather than the chemical itself. This suggests there are “many alcoholisms” rather than one single disease.

---

3. The DSM: The “Good, the Bad, and the Ugly”

The lecturer describes the Relationship between Psychiatry and Big Pharma as “Siamese Twins.”

• The Imperialistic Assault: The DSM is a tool for psychiatry to control the language of mental health and ensure they remain “captains of the ship.”
• The Reliability Problem: While the DSM-III introduced operational definitions to increase agreement between doctors, reliability for major disorders like anxiety and depression remains low (correlations as low as 0.20).
• The Billable Bible: The DSM serves two masters: scientific diagnosis and insurance billing. These goals are often at odds, leading to “garbage-can categories” like NOS (Not Otherwise Specified).

---

4. Emerging Paradigms: RDoC and HiTOP

Because the DSM is a “dictionary of symptoms” rather than a map of biology, new systems are being developed:

RDoC (Research Domain Criteria)

Initiated by Tom Insel (NIMH), this system moves away from DSM labels to a matrix of units. For example, “Fear” is studied across:

• Genes
• Molecules
• Cells/Circuits (e.g., the Amygdala)
• Physiology (e.g., startle response)

HiTOP (Hierarchical Taxonomy of Psychopathology)

This views mental illness as a hierarchy of dimensions rather than distinct categories. It focuses on symptoms that cluster together (e.g., the “Internalizing” arm includes fear, distress, and eating pathology).

---

5. The “P Factor” and the Dunedin Study

The Dunedin Longitudinal Study (New Zealand) followed individuals for over 25 years and discovered the $p$factor.

• General Psychopathology ($p$): Much like $g$ (general intelligence), $p$ represents a person’s underlying susceptibility to mental illness.
• Findings: High $p$ factor scores are correlated with:
  • Earlier brain health issues (at age 3).
  • Lower IQ scores.
  • Accelerated brain aging by age 38.
• Sankey Dynamics: The study showed that disorders are highly fluid; people move between categories (e.g., anxiety to depression) over their lifetime.

---

Key Takeaway: “A pile of bricks is not a house.” Science requires a theory (a plan) to organize facts. Currently, psychiatry is moving from a “naming” science to a “causational” science, but it has not yet arrived.

Diagnosing Abnormal Behavior

This lecture explores the methods and pitfalls of psychological assessment, moving from the human element (interviews) to the statistical (testing) and the biological (imaging). The professor argues that while biological measures are the current “breakthrough,” they are often treated as a “bandwagon” that ignores the psychosocial context of the individual.

---

1. The Lost “Whole Person” View: Multiaxial Assessment

The professor laments the removal of the Multiaxial System from the DSM. This system forced clinicians to look beyond the primary symptoms:

• Axis I & II: Clinical disorders and personality/intellectual deficiencies.
• Axis III: General medical conditions (e.g., diabetes).
• Axis IV: Psychosocial and environmental stressors (e.g., job loss)
• Axis V: Global assessment of functioning.

  The “Car Dealer” Case Study: A 45-year-old man presents with depression and is prescribed antidepressants. However, a multiaxial view reveals his depression is actually a reaction to impotencecaused by blood pressure medication, coupled with the stress of his car dealership facing bankruptcy. Without Axis III and IV, the treatment addresses the “mood” but misses the cause.

---

2. The Clinical Interview: A “Human” Fallibility

The interview is the most common diagnostic tool but also the least reliable and valid. It is highly susceptible to:

• The Power of Suggestion: If an authority figure (e.g., a prominent psychiatrist) suggests a “normal” patient is actually psychotic, up to 60% of other professionals will “see” that psychosis.
• Hypothesis Myopia: Clinicians often see what they are looking for based on who referred the patient (e.g., a neurologist vs. a psychologist).
• Memory Bias: In self-reporting (like the Australian gambling study), people remember wins and underestimate losses. Only 4% of gamblers accurately reported their outcomes.

---

3. Psychological Testing and the Prefrontal Cortex

The professor defends the General Factor of Intelligence ($g$) as a robust, though controversial, predictive tool.

• The Prefrontal Cortex (PFC): This is the “essence of thinking” and what separates humans from other primates. It handles abstract action and planning.
• Predictive Validity: Frontal lobe testing (like the abstract picture discrimination test) was found to be more predictive of grades at Harvard and managerial performance in corporations than standard IQ or interviews.
• The Interview Problem: Job interviews have a predictive value of only 0.13—essentially a waste of time—yet they remain the standard for hiring.

---

4. Biological Measures: Breakthrough or Bandwagon?

The lecture critiques the modern push toward purely biological definitions of mental illness.

The Problem of False Positives/Negatives

Every medical test has a margin of error. Using 2024/2025 data on COVID rapid antigen tests as an analogy:

• In a study of 900,000 tests, 42% of positives were false positives when compared to PCR results.
• This highlights the danger of treating a biological marker as “truth” without considering clinical context.

Brain Imaging (MRI, fMRI, PET)

While imaging provides a clear look at brain structure, its functional interpretation is complex:

• fMRI Limitations: It measures blood flow (oxygenation), not direct neural activity
• Generalized Responses: An area that “lights up” during a lie might also light up during a math problem; we are often measuring “decision making” rather than a specific “lying center.”
• Alcohol’s Effect: fMRI shows that alcohol shuts down the “anxiety centers” (amygdala/hippocampus), explaining why those with a high physiological risk for alcoholism use it to “self-medicate.”

---

5. Statistical Reality Check

The professor emphasizes that “names are bestowed, not found.” A diagnosis is a human construct, not a biological discovery.

• Leniency Error: In rating scales (like reference letters), everyone is an “A” student, making the measure meaningless.
• Projective Testing (Rorschach): Described as a “parlor game.” It relies on “magical thinking” and interpretation rather than objective norms.

---

Retention Strategy: The “Accordion” Summary

To help you retain this for your Obsidian research vault, here is the core logic:

1. Context Matters: Biological markers (Axis III) and life stress (Axis IV) often cause “mental” symptoms.
2. $g$ and the PFC: Cognitive ability is tied to the frontal lobe, which governs executive function and planning
3. The Error Margin: Always account for False Positives in both psych tests and biological screenings.

Influences on Mental Health

This lecture marks a pivotal transition into Etiology (the study of causation). The professor argues that abnormal behavior is not the result of a single “broken gene” or a simple chemical imbalance, but rather a complex, multi-level interaction between biological vulnerability and environmental stress.

---

1. The Nature-Nurture “Synergy”

The professor dismisses the nature-nurture debate as “stupid” because the two are inseparable.

• Epigenetics as a “Dimmer Switch”: Environment doesn’t just surround genes; it regulates them. Like a dimmer switch, the environment can “dial up” or “dial down” gene expression (RNA splicing, immune induction).
• The Dean Ornish Study: A key piece of evidence showing that lifestyle changes (nutrition/exercise) in men with prostate cancer changed the expression of over 500 genes in just three months.
• The Bullying Mouse: Social stress in mice was shown to alter 309 genes and change dopaminergic pathways, proving that behavior physically rewires genetic functioning.

---

2. Genetic Blueprints and Anomalies

While most mental illnesses are polygenic (involving many genes), the professor highlights specific conditions that serve as benchmarks for genetic research.

The Parental Age Factor

The lecture highlights a stark difference in mutation risk:

• Female germ cells: 22 cell divisions total.
• Male germ cells: 150 divisions by age 20; 840 divisions by age 50.
• This massive increase in cell division makes older fathers significantly more likely to pass on mutations linked to Autism, Schizophrenia, and Bipolar disorder.

---

3. The Synapse: Where Biochemistry Meets Behavior

The brain contains roughly 86 billion neurons and 600 trillion synapses. The professor explains that mental health “theory” is often just a backward calculation from drug effects.

• The Depletion Theory: When the drug Reserpine (used for blood pressure) depleted serotonin and caused depression, researchers concluded that “low serotonin = depression.”
• The Reuptake Mechanism: Drugs like Prozac work by blocking the reuptake of serotonin, leaving more of it in the synapse to bind with receptors.
• The Role of Glia: Previously dismissed as “glue,” we now know glial cells prune unused synapses and regulate the flow of information. They are increasingly seen as central to disorders like Autism.

---

4. The Dopamine Hypothesis and ADHD

The professor uses ADHD as a primary example of how biochemistry and behavioral management collide.

The ADHD Profile

• The Dopamine Link: ADHD is associated with the DRD4 gene and density abnormalities in dopamine transporters.
• The Treatment Paradox: Ritalin, a stimulant that mimics dopamine, is effective in 80% of cases because it provides the “stimulation” the frontal lobe is lacking.
• Comorbidity: 70% of ADHD children have a second disorder (ODD, Conduct Disorder, or Depression).

Behavioral Intervention vs. Surgery

The professor recounts a powerful clinical story about two hyperactive children scheduled for amygdalotomies (brain surgery). Instead of surgery, he used an Operant Conditioning system:

• The “Points” System: Using a chair with a microswitch to reward “sitting behavior” with toys/stamps.
• The Lesson: Even highly “physiological” behaviors can often be managed or redirected through behavioral training, potentially saving patients from invasive neurological procedures.

---

5. Endophenotypes: The “Missing Link”

Since there is no “schizophrenia gene,” researchers look for Endophenotypes—observable traits that are more closely tied to genetics than the full-blown disorder.

• Examples include: Problems in working memory, “gating” information (filtering noise), and abnormal eye movements.
• These traits exist in a “hidden” layer between the DNA and the clinical diagnosis.

---

The Professor’s Final Thought: “For $400, you can get some risk genes determined, thus turning dubious probability into ‘genes of doom.’” We must be careful not to let genetic probability dictate our destiny.

Brain Health and Mental Illness

This final lecture serves as a deep dive into the neuroanatomy and biochemistry of “being human,” focusing on the interplay between the limbic system (the ring of emotion) and the frontal lobes (the center of logic). The professor concludes that while we are discovering massive amounts of biological data, the clinical “cure” remains elusive because we are still struggling to define the target.

---

1. The Dopamine Economy: Reward and Addiction

Dopamine is the primary neurotransmitter of the mesolimbic system, which governs survival.

• The Survival Loop: This system evolved to reinforce the Four Fs: Feeding, Fighting, Fleeing, and Mating.
• Substance Abuse: Nearly every drug of abuse (cocaine, alcohol, amphetamines) artificially spikes dopamine in the nucleus accumbens.
• The Malleability of Brain Wiring: The professor cites the 1960s study of a male prostitute (Bob Heath) who, through septal area stimulation, shifted his sexual orientation. This suggests the brain is far more “plastic” than deterministic models allow.

---

2. The Limbic System: Fear vs. Context

The Amygdala is the brain’s “emergency response” center. By default, it labels incoming stimuli as fearful.

• The Antelope Analogy: An antelope running blindly into a lion’s den illustrates how anxiety paralyzes productive response.
• The Hippocampus: This acts as the brake, telling the amygdala, “We’ve seen this before; it’s safe.”
• Case Study (Charles Whitman): The 1966 UT Austin sniper was found to have a walnut-sized tumor pressing against his amygdala, offering a biological explanation for his sudden, uncontrollable aggression.

---

3. The Frontal Lobe: The “120% Difference”

The human frontal lobe is roughly 102–120% larger than that of our primate relatives. It is responsible for foresight, impulse control, and social appropriateness.

• Phineas Gage: The classic case of a railroad worker whose personality shifted from reputable to “reprobate” after a metal rod destroyed his frontal cortex.
• Concussion & Trauma: NFL and soccer players are at high risk for Chronic Traumatic Encephalopathy (CTE). Data shows a direct correlation: as concussion scores rise, so do depression scores.
• The “No-Brain” Student: A remarkable study of a student with an IQ of 126 but a brain consisting of only a 1mm layer of cortex due to hydrocephalus. This challenges the idea that “more tissue = more intelligence.”

---

4. Schizophrenia: The Thalamic Filter

Schizophrenia remains the “poster child” for the medical model because its biological markers are the most distinct.

---

5. ADHD: The Attention Paradox

The professor notes that ADHD treatment (Ritalin) has a high success rate (80%) but carries a secret: it works on “normal” people too.

• The Performance Enhancer: Ritalin/Adderall improves focus for anyone, which is why it is often diverted for academic “doping.”
• Comorbidity: ADHD is rarely alone; it is frequently paired with Conduct Disorder (trouble with the law) or Depression.
• The Stability Solution: When asked what provides the most successful opportunity for the next generation, the professor’s answer was singular: “A stable family at home.”

---

The “Inner Peace” Dog Test

The professor concludes the series with a humorous check for mental health. You have reached “inner peace” if you can:

• Start the day without caffeine.
• Eat the same food every day and be grateful.
• Take criticism without resentment.
• Relax without alcohol and sleep without drugs.
• …Conclusion: If you can do all this, you are likely a dog, not a human.

---

The Professor’s Final Outlook: In a world where religion and collective identity are shifting or “crushing,” the state of society controls what we view as normal. While we seek biological “genes of doom,” the context of our lives—our families and social connections—remains the most powerful intervention.

A Rise in Depression

This lecture marks the transition from the theoretical foundations of Abnormal Psychology 1 (definitions, assessment, and general theories) to the specific study of clinical disorders in Abnormal Psychology 2. The focus is heavily weighted toward Depression, its clinical presentation, and the alarming trends in youth mental health.

---

1. Recap: The State of the Field

The professor begins by reiterating the core critiques from the previous course:

• Disorder Inflation: The DSM has grown from 128 disorders in 1952 to 543 today. This suggests that while we are “naming” more behaviors, we aren’t necessarily “curing” them.
• The “Naming” Fallacy: Names like “Schizophrenia” are bestowed labels, not biological discoveries.
• Primitive Assessment: Despite a biological bias in psychiatry, most diagnoses still rely on the clinical interview, which is prone to high levels of bias and manipulation.
• Trial-and-Error Treatment: Because we treat depression as a single ubiquitous condition rather than a group of disorders with different causes, treatment remains largely unrefined.

---

2. The Landscape of Depression

Depression is the leading cause of disability for women and the second leading cause overall (behind heart disease).

Current Statistics (2023–2025 Context)

• Prevalence: ~20% of Americans (50 million) experience mental illness; over half remain untreated.
• The Gender Gap: Lifetime risk is 10–25% for women and 5–12% for men.
• The GP Problem: Most antidepressants are prescribed by General Practitioners, not specialists. Studies suggest GPs have a 25% error rate (false positives/negatives) compared to the “gold standard” of psychiatric evaluation.

The “Unhappy Young”

In a notable shift, the World Happiness Report shows that while Finland and Denmark remain the happiest, young people (under 30) in the US and Canada are “outliers” of unhappiness, ranking significantly lower than their older counterparts (US ranks 62nd for youth happiness).

---

3. Symptom Clusters in Depression

Depression is categorized into four primary clusters based on a factor analysis of the Beck Depression Inventory:

Note on Reality: Interestingly, depressives are often “closer to reality” than non-depressives because they see the “negative truth” of a situation that others might gloss over with “rose-colored glasses.”1

---

4. The Spectrum of Mood Disorders

The lecture distinguishes between several types of depressive and manic episodes:

• Major Depressive Disorder (MDD): Requires at least 5 symptoms over a 2-week period. It is often chronic and episodic; if you have had three episodes, there is a 90% chance of a fourth
• Bipolar Disorder: Characterized by “crashing lows” and “manic highs.”3 Manic episodes involve inflated self-esteem, flight of ideas, and risky goal-directed behavior (e.g., trying to buy a ski hill on a whim)
• Dysthymia: A persistent, lower-grade “depression lite.”5
• Seasonal Affective Disorder (SAD): Responds well to light therapy (2,500+ lux)
• Postpartum Depression: Affects 7–9% of women; can have severe effects on mother-child attachment.

---

5. The Youth Crisis and the “Screen Time” Debate

The professor highlights a dramatic up-curve in depression and self-harm among teens (especially girls) starting around 2011–2012.

• The Smartphone Variable: While the smartphone became ubiquitous around 2012, data suggests that “hanging out with friends” and “dating” began to decline in the early 1990s.
• South Australian Study: A survey of 50,000+ kids showed a precipitous drop in optimism, perseverance, and emotional regulation between 2017 and 2022.
• Social Isolation: Media use is strongly correlated with both internalizing (depression) and externalizing (conduct) disorders.

---

A Personal Perspective

The professor read a letter from a student who had a “perfect” childhood but still fell into a deep MDD during university. It serves as a reminder that:

1. MDD can strike anyone, regardless of a lack of obvious risk factors
2. Physical symptoms (like thinking you have “Mono”) often mask the psychological reality.
3. Family history is a silent but powerful indicator.

Inside Depression

This lecture delves into the multi-faceted etiology of depression, exploring how biological “blueprints” interact with environmental stressors, and critiques the current state of pharmacological and psychological treatments.

---

1. Demographic and Biological Predictors

A major theme is the consistent sex difference in depression (women being significantly more likely to be diagnosed). The professor explores several avenues for this:

• The Sleep-Thinking Connection: A longitudinal study found that sleep problems are the most significant initial predictor, leading to repetitive negative thinking, which then blossoms into depression.
• Hormonal Influences: There is strong evidence linking reproductive events—pregnancy (20% of women), postpartum (10-15%), and menopause—to depressive onset. The use of oral contraceptives, particularly in teens, is associated with higher depression scores.
• The “Masked Depression” Theory: The idea that men express depression through externalizing behaviors (like alcohol abuse) is noted as an interesting, though currently untestable, hypothesis.

---

2. Genetics and Biochemistry

While depression runs in families, identifying specific “depression genes” is significantly harder than in other disorders ($1$ in $1,500$ cases to find a new locus compared to $1$ in $230$ for schizophrenia).

• The $p$ Factor: There appears to be a generalized heritability for psychopathology rather than a specific “depressive gene.”
• The Serotonin Theory: This theory is largely “backward-engineered” from drug effects. Because SSRIs increase serotonin in the $5\text{-HT}$ synaptic cleft and improve mood, it was assumed a deficiency caused the problem. However, the professor notes that when the placebo effect is removed, the true effectiveness of these drugs is only about 10%.
• Gene-Environment Interaction: A study of Russian juveniles showed that a specific dopamine genotype only led to depression if the individual had also been rejected by their mother.

---

3. Psychological Models of Depression

The professor organizes the various psychological explanations into several historical and modern frameworks:

---

4. The Treatment Landscape: From SSRIs to Psychedelics

The lecture highlights a “trial-and-error” approach to treatment, emphasizing that most prescriptions are written by GPs in “revolving door” appointments rather than specialists.

• Pharmacology:
  • SSRIs: The most common, but slow-acting ($2\text{–}4$ weeks) and limited in effectiveness.
  • Ketamine/Spravato: Notable for its immediate effect, making it a vital tool for acute suicidal ideation.
  • Psychedelics (Psilocybin): Emerging as a “breakthrough” that affects the serotonergic system. However, the high cost of clinical monitoring may limit its adoption.
• Physical Interventions:
  • ECT (Electroconvulsive Therapy): Despite its “snake pit” reputation, modern ECT is highly effective for treatment-resistant depression and suicidal risk, acting much faster than medication.
  • Placebo Power: Brain scans show that placebos actually produce physical changes in the brain, accounting for a massive chunk of reported “improvement” in drug trials.

---

5. The Societal Context

The professor concludes by noting that the current “Age of Anxiety” and the rising unhappiness of the young (ranking 62nd in the US for those under 30) may stem from a lack of narrative framework.

• The Protective Power of Belief: Statistically, individuals with stable families, marriages, and religious or philosophical belief systems show higher resilience.
• The “Dirt Road” Analogy: Without a roadmap (tradition, religion, or a stable home), people are left on a “dirt road in the country,” which is inherently more stressful than having a defined path.

---

Key Takeaway: “Time is on the side of the depressive.” Most episodes naturally remit in 6–9 months, which is why many “treatments” appear more successful than they are biologically.

Recognizing Risk

This lecture concludes the discussion on depression treatments before transitioning into a somber, data-driven analysis of Suicide and Medically Assisted Dying (MAID). The professor contrasts the “barbaric” historical view of suicide with modern clinical and ethical dilemmas.

---

1. Advanced Interventions and the “Cognitive” Divide

The professor highlights that clinical efficacy often comes at the cost of “palatability.”

• ECT vs. TMS: ECT remains the “gold standard” for severe depression, far outperforming Ketamine and Transcranial Magnetic Stimulation (TMS). However, TMS is more common in clinics because it doesn’t require an MD or cause seizures.
• The 28% Rule: A study of over 1,000 patients identified a distinct subgroup (28%) of depressives with significant frontal lobe cognitive deficits.
  • Clinical Takeaway: Traditional CBT may be ineffective for this group because they lack the cognitive “hardware” to process the therapy’s logic.
• CBT & Mindfulness: For the majority, CBT offers the most enduring protection against relapse (72% success vs. 46% for drugs alone).

Digital & Lifestyle Interventions

• The App Paradox: The professor is skeptical of “digital therapeutics.” He notes that the FDA-approved app Rejoin was cleared despite data showing it doesn’t work, simply because “it doesn’t hurt anyone.”
• The “Family Glue”: A primary preventive measure for the youth mental health spike is the simple act of eating meals together at home without digital distractions—reclaiming the essence of social animals.

---

2. Suicide: Demographics and Geography

Suicide is described as an impulsive act often rooted in mental disorder, yet it has profound societal and economic impacts.

The Golden Gate Statistic

• The Golden Gate Bridge averages 30 jumpers per year.
• A steel mesh net, originally priced at $140 million, has ballooned to over $400 million in costs.
• Paradoxically, while the bridge gets a $400 million net, 50% of suicides involve firearms, which receive no such physical “nets.”

Risk Groups by Race and Profession

Global Outliers

• Lesotho: Highest suicide rate in the world (72.4 per 100,000). Driven by extreme poverty, high AIDS prevalence, and the loss of status for men returning from South African mines.
• Guyana: Second highest (40 per 100,000). Predominantly Indo-Guyanese farmers using pesticide overdoses.

---

3. Medically Assisted Dying (MAID)

The professor provides a provocative comparison between “suicide” and “assisted death” in Canada.

• The Scale: From 2016 to 2022, 44,958 Canadians died via MAID—exceeding the number of Canadian soldiers lost in World War II.
• The Rate: MAID accounts for 4.4% of all deaths in Canada (and 7% in Quebec).
• The Mental Illness Exclusion: Mental illness was excluded from MAID until 2023 because, as the professor notes, “we don’t know what it is,” making it nearly impossible to judge if someone “should” die for a psychological reason.

---

4. Deconstructing Suicide Fallacies

The lecture challenges “common sense” beliefs with longitudinal data:

• The “Spring” Peak: Suicide does not peak in winter. It peaks in April/Spring. This is a “contrast effect”—when the world gets better/brighter, the individual’s inner turmoil feels more acute.
• The “Diving Board” Effect: Threatening suicide is a major warning sign. 75% of victims provide warnings. Furthermore, surviving an attempt often makes the next one easier, as the “fear of the act” is diminished.
• Suicide Notes: Only one-third of people write them. They rarely explain “why”; instead, they usually range from logistical lists of possessions to deeply conflicted emotional outbursts (e.g., “I hate you, love John”).

---

Final Insight: “The secret to being miserable is to have the leisure to bother about whether you’re happy or not.” — George Bernard Shaw.

Reducing Risk

This lecture explores the complex distinction between suicidal attempters and completers, the role of the act as a form of social communication, and the shifting landscape of suicide and medically assisted dying.

---

1. Suicide as Communication: The Gesture vs. Lethality

Professor Pihl distinguishes between a “suicidal gesture” (often a cry for help or social communication) and a “suicidal completion.”

• The Social Operant: In some cases, the act is meant to deliver a message.
  • Example 1: A 17-year-old girl nicks her wrists in an ER to get her parents’ attention. This is a gesture with low lethality but a high desire for a social response.
  • Example 2: A woman attempts to signal her husband by starting a car in a closed garage, timed for his arrival. Because he misses his train, the intended “message” becomes a fatal accident.

Clinical Profile: Attempters vs. Completers

---

2. Medically Assisted Dying (MAID) and the “Slippery Slope”

The lecture addresses Canada’s status as a world leader in Medically Assisted Dying (MAID).

• Scale of Impact: From 2016 to 2022, nearly 45,000 Canadians used MAID.
• The Mental Health Exclusion: Mental illness was specifically excluded (temporarily) because of the difficulty in judging the “permanency” of a psychological problem.
• The Ethical Concern: The professor warns of the “slippery slope” where the government’s need for organ donations might eventually intersect with the facilitation of assisted deaths.

---

3. Classifications and Predictors

Suicide can be categorized into five distinct classes based on data from 300,000 cases:

1. Physical Health Problems (Class IV): The most consistent predictor, especially among the elderly and sick.
2. Poly-substance Problems (Class V): A rapidly increasing category since 2012.
3. Mental Health & Substance Problems.
4. Mental Health only.
5. Alcohol & Intimate Partner Problems.

High-Risk Groups

• Professions: Doctors, dentists, police officers, and veterinarians. These are high-status but high-stress jobs with “lives in their hands” but often low personal control over bureaucratic systems.
• Indigenous Populations: Aboriginal males (15–24) and Native Americans/Alaskan Natives face astronomical rates of suicide linked to systemic stress and loss of status.
• Geography: Lesotho has the highest global rate, attributed to high AIDS prevalence and a country in transition where men have lost traditional roles as miners.

---

4. Theoretical Frameworks

• Emil Durkheim (Sociological):
  • Egoistic: The person doesn’t belong to any group; they have no “glue.”
  • Altruistic: The individual is so absorbed by the group (e.g., Al-Qaeda, Jonestown) that they die for its cause
  • Anomic: Rapid societal or personal change (e.g., winning the lottery or sudden fame) that a person cannot cope with.
• Sigmund Freud (Psychological): Proposed the Thanatos (death instinct), though Pihl notes this is largely a circular and uninformative theory
• Edwin Schneidman (Clinical): Viewed the mind as a “Congress” debating whether to live or die. Most warnings are direct or indirect “cries for help.”

---

5. Prevention and the Role of Society

• The Discharge Window: The most dangerous time for a patient treated for depression is the first few days/weeks after discharge. Patients often use their time in the hospital to plan their final act.
• The Best Preventative: Social Support. Every standard deviation increase in social support significantly lowers the odds of suicide attempts and severe depression.
• Media Contagion: The Netflix series 13 Reasons Why was linked to a 12–27% increase in youth suicides, illustrating the danger of “sensationalizing” or “normalizing” the act.

  The Professor’s Mantra: Suicide is a “permanent solution to a temporary problem.” While some cases (terminal illness) are distinct, for the majority, the feelings of disaster are transient.

The Scope of Maps & Genre/Addiction

This lecture provides a comprehensive overview of Addiction, moving from behavioral habits like smartphone use to the severe biological realities of the opioid crisis. The professor argues that while the DSM-V classifies addiction as a “chronic relapsing brain disease,” the social context and potency of the drugs (especially modern cannabis and fentanyl) are the true drivers of the current epidemic.

---

1. Defining Addiction: The Digital and Chemical Spectrum

The DSM-V identifies two main categories: Substances and Gambling, but the list is expanding to include “Internet Gaming Disorder” and “Caffeine Use Disorder.”

• The Smartphone Habit: * 89% of Americans check their phones within 10 minutes of waking.
  • 55% of users text while driving—a behavior six times more dangerous than drunk driving.
  • The “Idiot” Generation: Citing Albert Einstein, the professor warns that when technology surpasses human interaction, we risk a loss of human intelligence and social cohesion.
• AI Extinction Risks: Domain experts recently estimated a 20% chance of a global catastrophe (killing 10% of the population) by 2100, with AI being the primary threat.

---

2. The Medical Model: Addiction as a Brain Disease

The DSM-V defines addiction as a chronic, relapsing brain disease. It provides 11 criteria to measure severity:

Key Symptoms include: Taking larger amounts than intended, persistent desire to cut down, failure to fulfill roles at work/home, and the development of tolerance (needing more for the same effect) and withdrawal.

---

3. The Natural History of Drug Use

The professor debunks William Osler’s claim that only humans take drugs.

• Animal Consumption: Elephants in India get drunk on rice beer; moose consume hallucinogenic mushrooms; monkeys seek out intoxicating tubers.
• Historical Roots: Paleolithic cave drawings suggest hallucinogenic use predates history. Every civilization has used substances (Scythians with cannabis, Incas with coca, Egyptians with beer and opium).
• The “Soothing Syrup”: In 1908, the Sears catalog sold opium-laced syrup to “soothe” crying babies, highlighting how societal norms regarding “safe” drugs change over time.

---

4. The Modern Crisis: Fentanyl and “Iso”

The potency of manufactured narcotics has fundamentally changed the risk of death.

• The Potency Scale: * Heroin: Baseline.
  • Fentanyl: 50 times more powerful than heroin.
  • Isotonitazene (“Iso”): 250 times more powerful than heroin.
• Fentanyl “Pollution”: A study in New York found that 87% of street drug users were consuming fentanyl without knowing it; it is mixed into cocaine and other substances to increase addiction.

---

5. The Policy Debate: Decriminalization vs. Harm Avoidance

The professor critiques recent shifts in drug policy in North America.

• The “Portugal Model” Failure: While Portugal successfully used decriminalization, the same approach in Oregon and British Columbia (BC) has led to a “public uprising.”
• The BC Reversal: Decriminalization led to drug use spreading into public spaces like libraries. Consequently, the BC government is now seeking to roll back these laws.
• Harm Avoidance: Focuses on Naloxone (opioid blocker) and fentanyl strips to prevent death, but doesn’t necessarily address the root of addiction.

---

6. Alcohol and Cannabis: The “Social” Drugs

• Alcohol: The third most prevalent health problem globally. It is involved in 50% of violent crimes and 50% of rapes, largely because it dampens the brain areas (frontal lobes) that allow for evaluative thinking.
• The Cannabis Dosage Shift: * 1970s (The Jamaica Study): Professor Pihl’s research in Jamaica found that “Ganja” with 6.7% THC had minimal neuropsychological effects on a healthy population.
  • 2020s: Modern cannabis often contains 20–30% THC. This massive increase in dosage is linked to frontal lobe brain defects and a surge in emergency room visits for “edible” overdoses.

---

Pharmacokinetics: The “How” Matters

The effect of any drug is a function of:

1. Dosage: High-potency modern drugs change the brain faster.
2. Route of Administration: Smoking or injecting causes a “spike” in dopamine, whereas pills are slower and generally less addictive.
3. Metabolism: Age, gender, and body weight dictate how long a drug stays in your system.

Breaking the Cycle

This concluding lecture synthesizes global drug trends, the neurobiology of reward, and a revolutionary approach to prevention based on personality-targeted interventions. The professor argues that to solve the addiction crisis, we must shift our focus from studying “the explosion” (current addicts) to “the trigger” (those at high risk).

---

1. Global and Demographic Trends (2021–2023)

• Global Increase: Drug use has risen to nearly 300 million people worldwide, a 23% increase.
• The Rankings: Cannabis is the most used drug, followed by opioids and amphetamines.
• Age of Onset: Heavy use peaks in the 20s.
• Comorbidity: The mental health disorder most likely to be paired with drug use is Intermittent Explosive Disorder, followed closely by ADHD.
  • The ADHD Complication: In one study, up to 75% of adults prescribed stimulants for ADHD were found to be selling their medication, complicating the “treatment” landscape.

---

2. High-Risk Research: The “Trigger” Strategy

The professor advocates for High-Risk Research, which tracks individuals who are biologically prone to addiction before they develop a problem.

• The Explosion vs. The Trigger: Studying current addicts only shows the damage (“the explosion”). Studying at-risk youth allows researchers to see the “triggering mechanism” and understand why some people remain resilient.
• The “Sons of Alcoholics” Findings: * Males with a multi-generational family history of alcoholism show a hyper-reactive heart rate when intoxicated.
  • For these individuals, alcohol is more than a relaxant; it is a powerful reward.
  • Crucially, when drunk, their physiological response to stress (electric shocks) actually goes down. Alcohol effectively “negates” the aversive parts of reality for them.

---

3. The Neurobiology of “Control”

The lecture reinforces that addiction is fundamentally tied to the Dopaminergic System (the Mesolimbic pathway).

• The Nucleus Accumbens: This is the “ground zero” for reward. Drugs like fentanyl, cocaine, and even high-stakes gambling artificially flood this area with dopamine.
• The DRD2 Gene: A genome-wide study of 1 million users identified this dopamine receptor gene as a primary marker for susceptibility.
• The Tolerance Trap: Chronic use decreases the brain’s natural dopamine production, requiring more of the drug just to feel “normal.”

---

4. The Industry and Policy Critique

The professor provides a sharp critique of the “Medical-Industrial Complex”:

• Marketing vs. Science: Pharmaceutical companies spend more on marketing (6–8 billion annually) than on R&D. They often “create diseases” to sell products.
• GP Error Rates: Roughly 60% of people in a doctor’s office are not physically ill but are seeking solutions to “problems in living.” Because doctors lack time, they often prescribe antidepressants or anxiolytics as a default.
• The “DARE” Paradox: Generalized prevention programs like DARE often increase drug use because they inadvertently pique the curiosity of sensation-seeking youth.

---

5. The SURPS Model: Targeted Prevention

The most hopeful part of the lecture focuses on Personality-Targeted Interventions (The SURPS Scale). Instead of a “one-size-fits-all” message, kids are categorized into four risk profiles:

The Four Personality Risk Factors

The Result: Very brief, targeted interventions (just 30–90 minutes) in schools have shown a dramatic reduction in binge drinking, illicit drug use, and even shoplifting for up to 24 months.

---

Conclusion: The “Dog Test” for Inner Peace

The professor closes the series by reiterating that until we reach a societal consensus and provide stable families, our mental health strategies will remain fragmented. He repeats his humorous test:

If you can ignore aches and pains, eat the same food every day with gratitude, and sleep without drugs… then you’re a dog. For humans, the path to “inner peace” is infinitely more complex, requiring a balance of biology, psychology, and a stable social narrative.

---